The US Food and Drug Administration granted clearances for testing instruments, a blood clot drug companion diagnostic test, and infectious disease tests, among other devices.

NEW YORK — Abbott on Wednesday announced that its Q1 2025 Diagnostics revenues declined 7 percent year over year, while its total revenues grew 4 percent. For the three months ended March 31, Abbott ...

VIENNA – Irish researchers presented data Saturday at the European Society of Clinical Microbiology and Infectious Diseases ...

NEW YORK – NanoSpeed Diagnostics announced on Tuesday that it has obtained regulatory approval in Canada for a qualitative test to assess vitamin D in a fingertip blood sample at the point of care.

The agency could continue to pursue more extensive LDT oversight by tightening control over items like RUO reagents and specimen collection devices.

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.

The firm raised the money last week in a public offering of 14,375,000 common shares, and it will use the money for working capital and general corporate purposes.

The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

The all-stock deal combines Longevity's human longevity and health aging products with 20/20s lab tests including its OneTest multi-cancer early detection assay.

NEW YORK – Cancer Research Horizons, a translational subsidiary of Cancer Research UK, announced on Monday that it has awarded £230,000 ($302,582) to researchers at the University of Birmingham to ...

NEW YORK – Cancer Research Horizons, a translational subsidiary of Cancer Research UK, announced Monday that it has awarded £230,000 ($302,582) to researchers at the University of Birmingham to ...